1-4 of 4
Geoffrey G. Fell
Close
Sort by
Journal Articles

Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia

Salma Parvin, Aditi Aryal, Shanye Yin, Geoffrey G. Fell, Matthew S. Davids, Catherine J. Wu, Anthony Letai
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5877–5889.
https://doi.org/10.1182/bloodadvances.2022008207
Published: 2023
Includes: Supplemental data
Journal Articles

Correcting the record on anemia of aging: a statistical reanalysis

Geoffrey G. Fell, David G. Nathan, Donna S. Neuberg
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3642–3643.
https://doi.org/10.1182/bloodadvances.2023010311
Published: 2023
Journal Articles

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential

Clinical Trials & Observations
Tal Sella, Geoffrey G. Fell, Peter G. Miller, Christopher J. Gibson, Shoshana M. Rosenberg, Craig Snow, Daniel G. Stover, Kathryn J. Ruddy, Jeffrey M. Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Elizabeth Frank, Donna S. Neuberg, Benjamin L. Ebert, Ann H. Partridge
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6151–6161.
https://doi.org/10.1182/bloodadvances.2022008376
Published: 2022
Includes: Supplemental data
Journal Articles

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy

Peter G. Miller, Adam S. Sperling, Elliott J. Brea, Mark B. Leick, Geoffrey G. Fell, Max Jan, Satyen H. Gohil, Yu-Tzu Tai, Nikhil C. Munshi, Catherine J. Wu, Donna S. Neuberg, Marcela V. Maus, Caron Jacobson, Christopher J. Gibson, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2982–2986.
https://doi.org/10.1182/bloodadvances.2021004554
Published: 2021
Includes: Supplemental data